According to “Global Cancer Statistics- 2022”, colorectal cancer (CRC) ranks third in incidence and second in cancer-related ...

Drug Hunter, the leading knowledge platform for drug discovery R&D teams, today announced the appointment of Dr. Lori ...

Novel trial designs like basket, umbrella, and platform trials enhance efficiency and reduce development timelines in precision medicine. Basket trials test a single therapy across different tumor ...

According to "Global Cancer Statistics- 2022", colorectal cancer (CRC) ranks third in incidence and second in cancer-related mortality. Given that ...

Emerging research highlights the transformative potential of m6A RNA modification in the diagnosis and treatment of cardiovascular diseases (CVDs).

Eli Lilly will partner with Insilico Medicine on an artificial intelligence (AI)-based drug development collaboration that they said could generate “over $100 million” for the AI drug discovery ...

GEN2 was evaluated in adult patients with advanced solid tumors in an intravenous dose escalation Phase 1 study GEN2 is well-tolerated, with no Dose Limiting Toxicity or treatment-related ...

By fusing enzyme fragments to antibodies, researchers from the Institute of Science Tokyo, in Japan, developed an innovative enzyme switch called "Switchbody," which is activated when bound to its ...

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions ...

One person's side effect could be another person's treatment if we expand our perspective on small molecule drug targets, ...